mamanamsai-shutterstock-com

mamanamsai / Shutterstock.com

15 June 2016Big Pharma

Hospira successfully revokes Cubist patents

The English High Court made its decision on the UK Hospira and Cubist Pharmaceuticals patent dispute last Friday, June 10, concluding that three Cubist-owned patents are invalid.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic